General Atlantic is exploring the sale of OneOncology, an operator of independent cancer-care practices, according to people with knowledge of the matter. The growth equity-focused investment firm, which has backed OneOncology since 2018, is working with an adviser to solicit interest in the Nashville, Tennessee-based company, which could fetch more than $2 billion including debt in a sale, said the people, who asked not to be identified discussing confidential information.
Read the full article: General Atlantic Is Said to Weigh $2B Sale of OneOncology //
Source: https://news.bloomberglaw.com/health-law-and-business/general-atlantic-is-said-to-weigh-2-billion-sale-of-oneoncology